jcrc333 blogspot.com

Immune Response BioPharma

A blog maintained by an investor in Immune Response Corporation now called Orchestra Therapeutics, Inc. OCHTQ.PK. Immune Response BioPharma claims to now own the research and trial results from Immune Response and is attempting to market their findings through the Immune Response BioPharma name.

OVERVIEW

This web page jcrc333.blogspot.com currently has a traffic ranking of zero (the lower the superior). We have explored nineteen pages inside the domain jcrc333.blogspot.com and found zero websites referring to jcrc333.blogspot.com.
Pages Crawled
19

JCRC333.BLOGSPOT.COM RANKINGS

This web page jcrc333.blogspot.com has seen a fluctuation levels of traffic within the past the year.
Traffic for jcrc333.blogspot.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for jcrc333.blogspot.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for jcrc333.blogspot.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

WHAT DOES JCRC333.BLOGSPOT.COM LOOK LIKE?

Desktop Screenshot of jcrc333.blogspot.com Mobile Screenshot of jcrc333.blogspot.com Tablet Screenshot of jcrc333.blogspot.com

JCRC333.BLOGSPOT.COM HOST

Our parsers identified that a lone page on jcrc333.blogspot.com took three hundred and twelve milliseconds to come up. We could not find a SSL certificate, so our crawlers consider jcrc333.blogspot.com not secure.
Load time
0.312 secs
SSL
NOT SECURE
Internet Protocol
172.217.10.33

WEBSITE IMAGE

SERVER OS AND ENCODING

I found that this domain is operating the GSE server.

PAGE TITLE

Immune Response BioPharma

DESCRIPTION

A blog maintained by an investor in Immune Response Corporation now called Orchestra Therapeutics, Inc. OCHTQ.PK. Immune Response BioPharma claims to now own the research and trial results from Immune Response and is attempting to market their findings through the Immune Response BioPharma name.

CONTENT

This web page jcrc333.blogspot.com states the following, "A blog maintained by an investor in Immune Response Corporation now called Orchestra Therapeutics, Inc." We saw that the webpage said " Immune Response BioPharma claims to now own the research and trial results from Immune Response and is attempting to market their findings through the Immune Response BioPharma name." It also said " Tuesday, June 18, 2013. David Buswell CEO Immune Response Biopharma responds to questions. Buswells reply to my letter. From David Buswell, CEO Immune Response BioPharma."

SEEK SIMILAR DOMAINS

Alternative Investment Manager - JCR Capital

JCR Capital is an alternative investment manager that provides capital solutions to middle market commercial real estate sponsors. JCR provides joint venture equity, preferred equity, structured debt and bridge loans for value-add, opportunistic and distressed transactions and special situations. Customized solutions for value-add and opportunistic transactions. Senior and subordinated financing for transitional and nearly-stabilized properties.

Jewish Community Relations Council of Atlanta Convening a common table for the Atlanta Jewish community.

Jewish Community Relations Council of Atlanta. Convening a common table for the Atlanta Jewish community. Officers and Board of Directors. This letter was sent to Senators David Perdue and Johnny Isakson. March 14, 2018 in Advocacy. Jewish Community Relations Council of Atlanta. Sent via e-mail and first-class mail. 455 Russell Senate Office Building. The cause is urgent; the time for action is now.

Home - Jewish Community Relations Council

Weekly Blog from Jeremy Burton, Executive Director.

JeffGOP.com Republican Party of Jefferson County WA

Best Video to Explain What is Happening in US Politics.